Molinar (Colecalciferol)

Colecalciferol is converted in the liver to 25‑hydroxyvitamin D and then in the kidney to the active hormone 1,25‑dihydroxyvitamin D. This active form binds to vitamin D receptors, increasing the expression of calcium‑binding proteins in the intestine, which enhances calcium and phosphate absorption and aids bone formation.

The appropriate dose of Molinar is determined by a qualified prescriber based on the patient’s serum vitamin D level, age, weight, and clinical condition. Dosage may vary from a single loading dose to daily maintenance therapy, and should follow the healthcare professional’s recommendation.

Safety data for colecalciferol in pregnancy and lactation are limited. It should only be used during pregnancy or while breastfeeding if the prescriber judges that the potential benefit outweighs any possible risk to the mother or infant.

To order Molinar, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Molinar provides colecalciferol, the natural form of vitamin D3, which is widely regarded for its efficacy in raising serum 25‑hydroxyvitamin D levels. Compared with synthetic analogues, it has a well‑established safety profile and is suitable for routine supplementation in deficiency states.

Molinar should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Molinar is taken orally, usually with water. It can be taken with or without food, but consistent administration with respect to meals helps maintain stable absorption. Follow the prescriber’s instructions regarding timing and frequency.

The most serious risk is hypercalcemia, which can cause nausea, vomiting, arrhythmias, and renal impairment. Patients with conditions that predispose to high calcium levels, such as sarcoidosis or hyperparathyroidism, should be monitored closely while using Molinar.

Molinar should be avoided in individuals with known hypersensitivity to colecalciferol or any excipients, and in patients with severe hypercalcemia, active granulomatous diseases, or uncontrolled hyperparathyroidism unless directed by a healthcare professional.